1 Stock That’ll Make You Turn Blue in the Face for Owning
Published on September 16, 2022
Biotech company bluebird bio (BLUE) received FDA approval for ZYNTEGLO last month, which seems to have boosted its stock price. However, given its bleak profitability and stretched valuations, the stock...